The impact of polyethylene glycol conjugation on bovine hemoglobin's circulatory half-life and renal effects in a rabbit top-loaded transfusion model

Artificial Organs

Volumn 21, Issue 8, 1997, Pages 907-915

  Conover, Charles D ^a   Gilbert, Carl W ^a   Shum, Kwok L ^a   Shorr, Robert G L ^a  

^a Enzon Incorporated   (United States)

Author keywords

glomerular filtration rate; hemoglobinuria; morphology; polyethylene glycol hemoglobin; urinalysis

Indexed keywords

BLOOD; MAMMALS; MORPHOLOGY; POLYETHYLENE GLYCOLS; POLYETHYLENES;

BLOOD CHEMISTRY; BOVINE HAEMOGLOBIN; EXCRETION RATES; GLOMERULAR FILTRATION RATE; HAEMOGLOBINS; HALF LIVES; HEMOGLOBINURIA; POLYETHYLENE GLYCOL HEMOGLOBIN; RENAL FUNCTIONS; URINALYSIS;

HEMOGLOBIN;

HEMOGLOBIN DERIVATIVE; MACROGOL;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; GLOMERULUS FILTRATION RATE; INTRAVENOUS DRUG ADMINISTRATION; MORPHOLOGY; NONHUMAN; PRIORITY JOURNAL; RABBIT; URINALYSIS;

ANIMALIA; BOVINAE; GLOMERULUS; ORYCTOLAGUS CUNICULUS;

EID: 0030871422     PISSN: 0160564X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1594.1997.tb00250.x     Document Type: Article

References (48)

1. Bucci E, Fronticelli C. Hemoglobin as oxygen carrier in cell-free fluids. Md Med J 1992;41(6):527-31.
2. Relihan M, Litwin M. Effect of stroma-free hemoglobin solution on clearance rate and renal function. Surgery 1972; 71(3):395-9.
3. Nho K, Zapipsky S, Abuchowski A, Davis F. PEG-modified hemoglobin as an oxygen carrier. In: Harris JM, ed. Poly(ethylene glycol) chemistry: Biotechnical and biomedical application. New York: Plenum Press, 1992;171-82.
4. Nucci ML, Shorr R, Abuchowski A. The therapeutic value of poly(ethylene glycol)-modified proteins. Adv Drug Del Rev 1991;6:133-51.
5. Braun S, Weiss F, Keller A, Ciccone J, Preuss H. Evaluation of the renal toxicity of heme proteins and their derivatives: A role in the genesis and acute tubule necrosis. J Exp Med 11970;31:443-60.
6. Feola M, Somoni J, Tran R, Canizaro P. Nephrotoxicity of hemoglobin solutions. Biomater Artif Cells Artif Organs 1990;18(2):233-49.
7. Flamenbaum W, Gehr M, Gross M, Kaufman J, Hamburger R. Acute renal failure associated with myoglobinuria and hemoglobinuria. In: Brenner B, Lazarus K, eds. Acute renal failure. Philadelphia: W.B. Saunders, 1983:271-92.
8. Haupt A, Ochs R, Schubert G. Renal lesions in ischemic kidneys infused with haemoglobin: An electron microscopic study. Urol Res 1982;10:1-6.
9. Savitsky J, Doczi J, Black J, Arnold J. A clinical safety trial of stroma-free hemoglobin. Clin Pharmacol Ther 1978;23(1): 73-80.
10. Takahashi T, Iwasaki K, Malchesky P, Harasaki H, Matsushita M, Nosé Y, Rolin H, Hall P. Renal effects of multiple infusion of pyridoxalated-hemoglobin-polyoxyethylene conjugate (PHP) solution in dogs. Artif Organs 1993;17(3): 153-63.
11. Bradley R, Sloshberg S, Nho K, Czuba B, Shorr R. Production of PEG-modified bovine hemoglobin: Economics and feasibility. Artif Cells Blood Silbstil Immobil Biotechnol 1994;22(3):657-67.
12. Lumley J, Green C, Lear C, Angell-James J, eds. Essentials of experimental surgery. Boston: Butterworth, 1989.
13. Moss G, Gould S, Rosen A, Sehgal L, Sehgal H. Animal model for nephrotoxicity of haemoglobin tetramer. Lancet 1986;1:1219.
14. Rabiner S, Helbert J, Lopas H, Friedman L. Evaluation of a stroma-free hemoglobin solution for use as a plasma expander. J Exp Med 1967;26:1127-42.
15. Spector J, Wilson C, Crosby W. Coagulation studies and correlative histology during experimental hemoglobinemia in rabbits. Am J Pathol 1974;74:567-74.
16. Tam S, Wong J. Impairment of renal function by stroma-free hemoglobin in rats. J Lab Clin Med 1988;111:189-93.
17. White C, Murray A, Greene J, Smith D, Medina F, Makovec G, Martin E, Bolin R. Toxicity of human hemoglobin solution infused into rabbits. J Lab Clin Med 1986;108:121-31.
18. Stone A, Stein T, LaFortune J, Wise L. Renal vascular effects of stroma and stroma-free hemoglobin. Surg Gynecol Obstet 1979;149:874-6.
19. Lee R, Atsumi N, Jacobs E, Austen W, Vlahakes G. Ultrapure, stroma-free, polymerized bovine hemoglobin solution: Evaluation of renal toxicity. J Surg Res 1989;47:407-11.
20. Bunn H. The use of hemoglobin as a blood substitute. Am J Hematol 1993;42:112-7.
21. White C, Murray A, Smith D, Greene J, Bolin R. Synergistic toxicity of endotoxin and hemoglobin. J Lab Clin Med 1986; 108:132-7.
22. Anderson M, Mouritzer C, Gabrielli E. Mechanisms of plasma hemoglobin clearance and selective deposition in the liver and kidney: Serum haptoglobin levels and selective deposition in the liver and kidney. Ann Surg 1966;164:905-12.
23. Lathem W. The renal excretion of hemoglobin: Regulatory mechanisms and the differential excretion of free and protein bound hemoglobin. J Clin Invest 1959;38:652-8.
24. Bunn H, Esham W, Bull R. The renal handling of hemoglobin. I. Glomerular filtration. J Exp Med 1969;129:909-24.
25. Bunn H, Jandl J. The renal handling of hemoglobin. II. Catabolism. J Exp Med 1969;129:925-34.
26. Fuertges F, Abuchowski A. The clinical efficacy of poly(ethylene glycol)-modified proteins. J Controlled Release 1990;11: 139-48.
27. Lenz G, Junger H, Schneider M, Kothe N, Lissner R, Prince A. Elimination of pyridoxylated polyhemoglobin after partial exchange transfusion in chimpanzees. Biomater Artif Cells Immobilization Biotechnol 1991;19(4):699-708.
28. Matsushita M, Yabuki A, Chen J, Takahashi T, Harasaki H, Malchesky P, Iwashita Y, Nosé Y. Renal effects of pyridoxalated-hemoglobin-polyoxyethylene conjugate solution as a blood substitute in exchange transfusion. ASAIO Trans 1988; 34:280-3.
29. Matsushita M, Yabuki A, Malchesky P, Harasaki H, Nosé Y. In vivo evaluation of a pyridoxalated-hemoglobin-polyoxyethylene conjugate. Biomater Artif Cells Artif Organs 1988;16(1):247-60.
30. Takahashi T, Iwasaki K, Malchesky P, Harasaki H, Emoto H, Goldcamp J, Matsushita M, Nosé Y, Rolin H, Hall P. Effects of single-dose infusion of pyridoxalated-hemoglobin-polyoxyethylene conjugate solution on canine renal function. Artif Organs 1991;15(6):462-73.
31. Baker S, Dodds E. Obstruction of the renal tubules during excretion of hemoglobin. Br J Exp Pathol 1925;29:247-59.
32. Goldberg M. Studies of acute renal effects of hemolyzed red blood cells in dogs including estimations of renal blood flow with krypton. J Clin Invest 1962;41:2112-22.
33. Smith C, Schuschereba S, Hess J, McKinney L, Bunch D, Bowman P. Liver and kidney injury after administration of hemoglobin cross-linked with bis(3,5-dibromosalicyl) fumarate. Biomater Artif Cells Artif Organs 1990;18(2):251-61.
34. Maunsbach A, Madden S, Latta H. Light and electron microscopic changes in proximal tubules of rats after administration of glucose, mannitol, sucrose, or dextran. Lab Invest 1962;11: 421-32.
35. Friedman H, DeVenuto F, Lollini L, Mellick P, Zuck T. Morphological effects following massive exchange transfusions with stroma-free hemoglobin solution. I. Liver. Lab Invest 1978;39(2):167-77.
36. Brewer D, Heath D. Electron microscopy of anoxic inoculation in the liver cell and its comparison with sucrose vacudation. Am J Pathol 1965;90:437-16.
37. Trump B, Goldblatt P, Stowell R. Studies on necrosis of mouse liver in vitro: Ultrastructural alterations in the mitochondria of hepatic parenchymal cells. Lab Invest 1965;14: 343-61.
38. Duncan K, Seaton R, Savin V. Filtration by rat glomeruli after expansion of extracellular fluid volume. J Lab Clin Med 1986; 108:309-14.
39. Conover C, Linberg R, Nho K, Hashim M, Shorr R. Vascular persistence of polyethylene glycol (PEG) modified hemoglobin in rats and dogs. IBC blood substitutes and related products symposium Philadelphia, PA, 1993.
40. Conover C, Nho K, Linberg R, Hashim M, Shorr R. PEG-Hemoglobin effects on blood pressure and heart rate in the canine. IBC blood substitutes and related products symposium Philadelphia, PA, 1993.
41. Keipert P, Gomez C, Gonzales A, Macdonald V, Hess J, Winslow R. Diaspirin cross-linked hemoglobin: Tissue distribution and long-term excretion after exchange transfusion. J Lab Clin Med 1994;123:701-11.
42. Hsia J, Song D, Er S, Wong L, Keipert P, Gomez C, Gonzales A, Macdonald V, Hess J, Winslow R. Pharmacokinetic studies in the rat on an o-raffinose polymerized human hemoglobin. Biomater Artif Cells Immobilization Biotechnol 1992;20(2-4): 587-95.
43. Anderson P, Ning J, Biro G. Clearance of differentially labelled infused hemoglobin and polymerized hemoglobin from dog plasma and accumulation in urine and selected tissues. Biomater Artif Cells Immobilization Biotechnol 1992;20(2-4): 781-7.
44. Friedman H, DeVenuto F, Lollini L, Mellick P, Zuck T. Morphological effects following massive exchange transfusions with stroma-free hemoglobin solution. II. Kidney. Lab Invest 1979;40(6):655-67.
45. Miller F. Hemoglobin absorption by the cells of the proximal convoluted tubule in mouse kidney. J Biophys Biochem Cytol 1960;8:689-718.
46. Ericsson J. Transport and digestion of hemoglobin in the proximal tubule. II. Electron microscopy. Lab Invest 1965;14: 16-39.
47. Christensen E, Maunsbach A. Effects of dextran on lysosomal ultrastructure and protein digestion in renal proximal tubule. Kidney Int 1979;16:310-1.
48. Engberg A. Effects of dextran 40 on the proximal renal tubule. Studies on transfer maxima of glucose and hippuran in the rat. Acta Chir Scand 1976;142:172-80.